Elsevier

Surgical Neurology

Volume 71, Issue 1, January 2009, Pages 19-24
Surgical Neurology

Aneurysm
Stent/coil treatment of very large and giant unruptured ophthalmic and cavernous aneurysms

https://doi.org/10.1016/j.surneu.2008.01.025Get rights and content

Abstract

Background

Treatment of VLGUIA remains a challenge. To reduce mass effect and achieve complete occlusion, open surgery has been our favored treatment. However, endovascular therapy is preferred for lesions in the cavernous sinus or for older patients with complicating medical problems. The goal of this study is to investigate outcome of stent and/or coil treatment of VLGUIA.

Methods

Beginning in 2002, the neuroform stent has been available to the University of Texas Southwestern Medical Center in Dallas. Since then until 2006, 15 patients were treated for VLGUIA with stenting and/or coiling at this institution. These 15 patients were used for a retrospective analysis in this study.

Results

Median patient age was 65 years, median aneurysm size was 27 mm (20-37 mm), and median follow-up time was 22 months. Eight aneurysms were localized in the cavernous sinus and 7 at the ophthalmic segment of the internal carotid artery. Four aneurysms were completely occluded (100%); 3 aneurysms, nearly complete (90%-99%); and 8 aneurysms, partial (<90% occlusion). Twelve patients required retreatment. Final GOS was 1 (good recovery) in 11 patients, 2 (moderate disability) in 3 patients, and 3 (severely disabled) in 1 patient. No patient died or deteriorated.

Conclusions

Stent/coil management of VLGUIA is constantly evolving. Current treatment results are promising, with very low morbidity/mortality. Disadvantage is the frequent persistence of residual aneurysm.

Introduction

Unruptured giant intracranial aneurysms remain a challenge for the team of treating physicians. If left untreated, the risk of rupture resulting in the patient's death or disability is as high as 40% to 50% over a 5-year period [21]. Treatment, however, is complicated because of the giant size, partial thrombosis, calcification, and usually presence of a wide neck. Surgical options have been pioneered by CG Drake [6]. Since then, decompression of the aneurysm mass, complete exclusion from circulation, and clip ligation have been our favored treatment, if possible. Endovascular management with optional use of stenting is a newer and less invasive alternative. In light of the small number of very large and giant aneurysms (≥2 cm) and the recent evolution of stents, there are little data about treatment using all modalities available today. Various interventional treatment options are under debate [12], [18]. The goal of the present study is to investigate the outcome of stent and/or coil treatment of unruptured very large and giant intracranial aneurysms ≥2 cm starting at the time the neuroform stents became available.

Section snippets

Patients

Neuroform stents were introduced to our institution in 2002. Chart review revealed 95 patients who were treated for unruptured intracranial aneurysms ≥2 cm at the University of Texas Medical Center in Dallas between 2002 and 2006. Surgery was typically the treatment of choice to reduce the mass effect of the aneurysm. Seventy-four patients underwent surgery as the only treatment. Five patients underwent endovascular parent vessel sacrifice with good outcome. One patient's initial surgery was

Patient and aneurysm characteristics

There was a female predominance with 12 patients (75%); 3 patients were male (25%). The median age was 65 years (13-76 years). All patients presented with vision loss or diplopia attributable to cranial nerve compression by mass effect. Furthermore, 73% complained of headaches. Nine aneurysms were localized on the right side, 6 on the left. Eight aneurysms originated in the cavernous segment of the carotid artery. Seven aneurysms originated from the ophthalmic segment of the carotid artery. The

Discussion

The current study shows stent and/or coil treatment of very large and giant cavernous and ophthalmic aneurysms can be performed safely. Using current stent and coil equipment, morbidity and mortality can be very low. Rupture could be prevented at least during the median follow-up time of 22 months. Disadvantage of the stent/coil therapy is the frequently incomplete occlusion of the aneurysm with need for multiple treatments and follow-up angiography.

Conclusion

Endovascular treatment of giant intracranial aneurysms is constantly evolving as newer stent and coil technology becomes available. Using up-to-date equipment, stent/coil treatment of unruptured giant intracranial aneurysms is promising because it seems to be fairly safe and to cause some protection from rupture. Disadvantage is the often incomplete occlusion with unknown risk of future rupture. We believe stent/coil treatment represents a considerable alternative to surgical treatment of giant

Acknowledgment

We thank Jerri Thomas for her help. We further thank Suzanne “Jorlam” Truex for assistance with the figure.

References (21)

There are more references available in the full text version of this article.

Cited by (0)

View full text